Daewoong, Oscotec to develop new natural pharmaceutical product for arthritis
Published: 2008-09-12 06:54:00
Updated: 2008-09-12 06:54:00
Daewoong Pharm said on September 10 that it has signed a memorandum of understanding with Oscotec Inc., a local bone specialized bioengineering company to develop BT-201, a natural drug candidate for treatment of arthritis. The lead compound was funded by the government until 2006.
Under the a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
